Atypical antipsychotics in bipolar and schizoaffective disorders
No data are available comparing the relative efficacy of different atypical agents in patients with bipolar disorder. A chart review of bipolar and schizoaffective disorder patients who had received courses of at least two atypical agents (n = 33) in a community psychiatry system was conducted. No d...
Gespeichert in:
| Veröffentlicht in: | Pharmacopsychiatry 2001-03, Vol.34 (2), p.80-81 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 81 |
|---|---|
| container_issue | 2 |
| container_start_page | 80 |
| container_title | Pharmacopsychiatry |
| container_volume | 34 |
| creator | BROWN, E. S THOMAS, N. R CARMODY, T MAHADI, S NEJTEK, V. A |
| description | No data are available comparing the relative efficacy of different atypical agents in patients with bipolar disorder. A chart review of bipolar and schizoaffective disorder patients who had received courses of at least two atypical agents (n = 33) in a community psychiatry system was conducted. No differences in rates of hospitalizations were found between individual atypical agents or between atypical agents as a class and conventional neuroleptics. However, a significant reduction in rates of emergency room visits was found with atypical agents compared to conventional neuroleptics, with a trend toward greater reduction with clozapine compared to other atypical antipsychotics. Larger prospective studies are needed to confirm these preliminary observations. |
| doi_str_mv | 10.1055/s-2001-15179 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77056844</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77056844</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-d12f581a2c5f5aba043b59a47d864bcfc4ce414ab1d99692793f16fe9a7b4ff23</originalsourceid><addsrcrecordid>eNpF0M9LwzAUwPEgis7pzbMUBE9G85qkWW6O4S8YeNFzSNOERbq25nXC_OvtXNHTO7wPD96XkAtgt8CkvEOaMwYUJCh9QCYguKZMaXlIJgxUQXmh9Ak5RfwYmNCMH5MTAM5yWcwm5H7eb7vobJ3Zpo8dbt2q7aPDLDZZGbu2tmnYVBm6VfxubQje9fHLZ1XENlU-4Rk5CrZGfz7OKXl_fHhbPNPl69PLYr6kjoPsaQV5kDOwuZNB2tIywUuprVDVrBClC044L0DYEiqtC50rzQMUwWurShFCzqfken-3S-3nxmNv1hGdr2vb-HaDRik2PCTEAG_20KUWMflguhTXNm0NMLMrZtDsipnfYgO_HO9uyrWv_vGYaABXI7A4dArJNi7in9M5KCH5D3nic1w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77056844</pqid></control><display><type>article</type><title>Atypical antipsychotics in bipolar and schizoaffective disorders</title><source>MEDLINE</source><source>Thieme Connect Journals</source><creator>BROWN, E. S ; THOMAS, N. R ; CARMODY, T ; MAHADI, S ; NEJTEK, V. A</creator><creatorcontrib>BROWN, E. S ; THOMAS, N. R ; CARMODY, T ; MAHADI, S ; NEJTEK, V. A</creatorcontrib><description>No data are available comparing the relative efficacy of different atypical agents in patients with bipolar disorder. A chart review of bipolar and schizoaffective disorder patients who had received courses of at least two atypical agents (n = 33) in a community psychiatry system was conducted. No differences in rates of hospitalizations were found between individual atypical agents or between atypical agents as a class and conventional neuroleptics. However, a significant reduction in rates of emergency room visits was found with atypical agents compared to conventional neuroleptics, with a trend toward greater reduction with clozapine compared to other atypical antipsychotics. Larger prospective studies are needed to confirm these preliminary observations.</description><identifier>ISSN: 0176-3679</identifier><identifier>EISSN: 1439-0795</identifier><identifier>DOI: 10.1055/s-2001-15179</identifier><identifier>PMID: 11302568</identifier><identifier>CODEN: PHRMEZ</identifier><language>eng</language><publisher>Stuttgart: Thieme</publisher><subject>Adult ; Antipsychotic Agents - therapeutic use ; Biological and medical sciences ; Bipolar Disorder - drug therapy ; Bipolar Disorder - psychology ; Emergency Medical Services ; Female ; Hospitalization ; Humans ; Male ; Medical sciences ; Middle Aged ; Neuropharmacology ; Pharmacology. Drug treatments ; Psychiatric Status Rating Scales ; Psycholeptics: tranquillizer, neuroleptic ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Psychotic Disorders - drug therapy ; Psychotic Disorders - psychology ; Retrospective Studies</subject><ispartof>Pharmacopsychiatry, 2001-03, Vol.34 (2), p.80-81</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-d12f581a2c5f5aba043b59a47d864bcfc4ce414ab1d99692793f16fe9a7b4ff23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3017,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=921745$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11302568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BROWN, E. S</creatorcontrib><creatorcontrib>THOMAS, N. R</creatorcontrib><creatorcontrib>CARMODY, T</creatorcontrib><creatorcontrib>MAHADI, S</creatorcontrib><creatorcontrib>NEJTEK, V. A</creatorcontrib><title>Atypical antipsychotics in bipolar and schizoaffective disorders</title><title>Pharmacopsychiatry</title><addtitle>Pharmacopsychiatry</addtitle><description>No data are available comparing the relative efficacy of different atypical agents in patients with bipolar disorder. A chart review of bipolar and schizoaffective disorder patients who had received courses of at least two atypical agents (n = 33) in a community psychiatry system was conducted. No differences in rates of hospitalizations were found between individual atypical agents or between atypical agents as a class and conventional neuroleptics. However, a significant reduction in rates of emergency room visits was found with atypical agents compared to conventional neuroleptics, with a trend toward greater reduction with clozapine compared to other atypical antipsychotics. Larger prospective studies are needed to confirm these preliminary observations.</description><subject>Adult</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Bipolar Disorder - drug therapy</subject><subject>Bipolar Disorder - psychology</subject><subject>Emergency Medical Services</subject><subject>Female</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psycholeptics: tranquillizer, neuroleptic</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Psychotic Disorders - drug therapy</subject><subject>Psychotic Disorders - psychology</subject><subject>Retrospective Studies</subject><issn>0176-3679</issn><issn>1439-0795</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0M9LwzAUwPEgis7pzbMUBE9G85qkWW6O4S8YeNFzSNOERbq25nXC_OvtXNHTO7wPD96XkAtgt8CkvEOaMwYUJCh9QCYguKZMaXlIJgxUQXmh9Ak5RfwYmNCMH5MTAM5yWcwm5H7eb7vobJ3Zpo8dbt2q7aPDLDZZGbu2tmnYVBm6VfxubQje9fHLZ1XENlU-4Rk5CrZGfz7OKXl_fHhbPNPl69PLYr6kjoPsaQV5kDOwuZNB2tIywUuprVDVrBClC044L0DYEiqtC50rzQMUwWurShFCzqfken-3S-3nxmNv1hGdr2vb-HaDRik2PCTEAG_20KUWMflguhTXNm0NMLMrZtDsipnfYgO_HO9uyrWv_vGYaABXI7A4dArJNi7in9M5KCH5D3nic1w</recordid><startdate>20010301</startdate><enddate>20010301</enddate><creator>BROWN, E. S</creator><creator>THOMAS, N. R</creator><creator>CARMODY, T</creator><creator>MAHADI, S</creator><creator>NEJTEK, V. A</creator><general>Thieme</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010301</creationdate><title>Atypical antipsychotics in bipolar and schizoaffective disorders</title><author>BROWN, E. S ; THOMAS, N. R ; CARMODY, T ; MAHADI, S ; NEJTEK, V. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-d12f581a2c5f5aba043b59a47d864bcfc4ce414ab1d99692793f16fe9a7b4ff23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Bipolar Disorder - drug therapy</topic><topic>Bipolar Disorder - psychology</topic><topic>Emergency Medical Services</topic><topic>Female</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psycholeptics: tranquillizer, neuroleptic</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Psychotic Disorders - drug therapy</topic><topic>Psychotic Disorders - psychology</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BROWN, E. S</creatorcontrib><creatorcontrib>THOMAS, N. R</creatorcontrib><creatorcontrib>CARMODY, T</creatorcontrib><creatorcontrib>MAHADI, S</creatorcontrib><creatorcontrib>NEJTEK, V. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacopsychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BROWN, E. S</au><au>THOMAS, N. R</au><au>CARMODY, T</au><au>MAHADI, S</au><au>NEJTEK, V. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atypical antipsychotics in bipolar and schizoaffective disorders</atitle><jtitle>Pharmacopsychiatry</jtitle><addtitle>Pharmacopsychiatry</addtitle><date>2001-03-01</date><risdate>2001</risdate><volume>34</volume><issue>2</issue><spage>80</spage><epage>81</epage><pages>80-81</pages><issn>0176-3679</issn><eissn>1439-0795</eissn><coden>PHRMEZ</coden><abstract>No data are available comparing the relative efficacy of different atypical agents in patients with bipolar disorder. A chart review of bipolar and schizoaffective disorder patients who had received courses of at least two atypical agents (n = 33) in a community psychiatry system was conducted. No differences in rates of hospitalizations were found between individual atypical agents or between atypical agents as a class and conventional neuroleptics. However, a significant reduction in rates of emergency room visits was found with atypical agents compared to conventional neuroleptics, with a trend toward greater reduction with clozapine compared to other atypical antipsychotics. Larger prospective studies are needed to confirm these preliminary observations.</abstract><cop>Stuttgart</cop><cop>New York, NY</cop><pub>Thieme</pub><pmid>11302568</pmid><doi>10.1055/s-2001-15179</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0176-3679 |
| ispartof | Pharmacopsychiatry, 2001-03, Vol.34 (2), p.80-81 |
| issn | 0176-3679 1439-0795 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77056844 |
| source | MEDLINE; Thieme Connect Journals |
| subjects | Adult Antipsychotic Agents - therapeutic use Biological and medical sciences Bipolar Disorder - drug therapy Bipolar Disorder - psychology Emergency Medical Services Female Hospitalization Humans Male Medical sciences Middle Aged Neuropharmacology Pharmacology. Drug treatments Psychiatric Status Rating Scales Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Psychotic Disorders - drug therapy Psychotic Disorders - psychology Retrospective Studies |
| title | Atypical antipsychotics in bipolar and schizoaffective disorders |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A51%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atypical%20antipsychotics%20in%20bipolar%20and%20schizoaffective%20disorders&rft.jtitle=Pharmacopsychiatry&rft.au=BROWN,%20E.%20S&rft.date=2001-03-01&rft.volume=34&rft.issue=2&rft.spage=80&rft.epage=81&rft.pages=80-81&rft.issn=0176-3679&rft.eissn=1439-0795&rft.coden=PHRMEZ&rft_id=info:doi/10.1055/s-2001-15179&rft_dat=%3Cproquest_cross%3E77056844%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77056844&rft_id=info:pmid/11302568&rfr_iscdi=true |